 |
Projets(s) de recherche, responsable |
| |
 |
Chaire de recherche du Canada en maladies valvulaires cardiaques, Philippe Pibarot
|
| |
|
Circulating Anti-TREK-1 Autoantibodies as Diagnostic and Prognostic Biomarkers in Short-Coupled Ventricular Fibrillation, Christian Steinberg
|
| |
|
Identification de nouvelles cibles thérapeutiques pour corriger le remodelage pulmonaire et cardiaque associé à l'hypertension pulmonaire, Olivier Boucherat
|
| |
|
ImproviNg rEnal outcomes following coronary angiograPhy and/or percuTanaoUs coroNary IntErventions: a pragmatic, adaptive, patien-oriented randomized controlled trial, Tomas Cieza Lara
|
| |
|
LEFT HF: LEFT Bundle Pacing vs Standard Right Ventricular Pacing for Heart Failure, François Philippon
|
| |
|
One-month DAPT In CABG PatieNts: the ODIN trial, Pierre Voisine
|
| |
|
Optimization of a mouse xenograph platform to study BCC progression, Mélanie Laurin
|
| |
|
Replication stress and pulmonary hypertension: Role for checkpoint kinase 1
|
| |
|
Soutien au développement du Pôle d'excellence en santé des femmes et des minorités, Marie-Eve Piché
|
| |
|
Targeting Hypusine signaling: an opportunity to counter pulmonary vascular remodelling in pulmonary arterial hypertension, Sébastien Bonnet
|